Gain-of-function mutations in fibroblast growth factor receptor (FGFR) genes are known to cause a range of skeletal disorders, such as craniosynostosis and chondrodysplasia, which severely affect ...

The AHR Expo took over Orlando Feb. 10-12 for a week of learning, reconnecting, and checking out all the new products coming to market in HVACR. Key topics spanned tariffs, regulation updates, A2Ls, ...

ORLANDO, FL — The 2025 AHR Expo occupied the Orange County Convention Center February 10-12, hosting more than 1,800 exhibitors, and showcasing the latest technologies, products and services to an ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The role of salvage cystectomy after prior trimodality therapy. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text ...

LEM.V Leading Edge Materials Corp.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Pre-market: 7:22:26 am GMT-5 Loading Chart for AHR ...

The drug did not induce adverse events more commonly seen with erdafitinib, a drug typically used to treat the disease that targets all four FGFR isoforms.